Blockbuster new Biologic Drug

I was watching Mad Money when Cramer's guest discussed his company's newest blockbuster drug: Anti-TL1A Antibody. Before any of you scoff at this drug you need to realize that the TNFa drug, Humira, was one of the most profitable drugs ever discovered in the history of the pharmacy/biotech industry. This new biologic is likely going to pass the profitability of TNFa inhibitors as a class. Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study - PubMed https://clinicaltrials.gov/NCT02840721. pubmed.ncbi.nlm.nih.gov
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Anesthesiology Source Type: forums